Company Profile · Digital Health · Singapore
WhiteCoat Global
A doctor in your pocket and your medicine at the door - how a Singapore startup turned on-demand culture into a four-country healthcare group.
A doctor in your pocket and your medicine at the door - how a Singapore startup turned on-demand culture into a four-country healthcare group.
WhiteCoat Global is a digital healthcare provider built on a simple wager: if Singapore will summon a ride, a meal, or a parcel on demand, it will do the same for a doctor. Since launching in 2018, the company has let patients video-consult a licensed general-practice or family-medicine doctor from a smartphone, receive a prescription, and have medication delivered - often within hours - without setting foot in a waiting room.
What began as an app in one city is now an omnichannel group operating across Singapore, Indonesia, Malaysia and Vietnam. It positions itself as a first and single touchpoint for care: consultations, chronic-condition management, lab-result reviews, specialist referrals, travel medication, vaccinations and digital medical documentation, stitched together with medication fulfillment. The pitch is less "an app" and more "the front door to healthcare."
That video-first stance is a deliberate product choice. Where many telehealth services started with text chat, WhiteCoat built around live video so a doctor can actually see a patient and judge whether an in-person examination is needed. It is a small design decision with an outsized effect on trust - the currency any healthcare company ultimately trades in.
Figures reflect the combined WhiteCoat-Good Doctor group following the 2024 acquisition. Since 2023, WhiteCoat has delivered over 1.5 million consultations and medication fulfillments.
The story WhiteCoat tells about itself starts in 2016, when founder Bryan Koh - then a corporate lawyer - fell ill hours before a flight to South Africa. His sister Natalie, a doctor, assessed him remotely and got him sorted in time. The convenience of that moment became the question behind the company: why should everyone else have to lose half a day to see a doctor?
Koh's background matters. He was neither a physician nor an engineer; his edge was navigating regulation and partnerships. That shaped an approach of building with regulators rather than around them - WhiteCoat became the first startup accepted into Singapore's Ministry of Health telemedicine sandbox.
Traditional visits mean travel, queues and waiting rooms for issues that can be handled remotely.
A consult means little if the prescription takes days. WhiteCoat closes the loop with delivery.
Insurers and employers get a compliant, ready-made way to extend care to millions of members.
WhiteCoat's suite is designed to keep the whole journey inside one experience - diagnosis, prescription, delivery and follow-up.
Real-time video visits with licensed GP and family-medicine doctors, on demand.
Doorstep prescription fulfillment - express delivery in Singapore via a Grab partnership.
Ongoing management, refills and lab-result discussion for long-term conditions.
Digitally issued referral letters connecting patients to specialists and clinics.
End-to-end, customized employee health and telehealth coverage for companies.
Embedded and exclusive telehealth for insurers, reaching their member bases.
Directly, WhiteCoat earns from consultation fees, prescription charges and delivery fees. But its real distribution engine is B2B2C: insurers and corporate employers embed WhiteCoat as their telehealth provider, handing the company access to millions of insured lives and employees without direct-to-consumer ad spend.
The pivotal example came in 2019, when WhiteCoat became AIA Singapore's exclusive telehealth provider - opening a door to roughly two million users overnight. Distribution, in this model, beats marketing.
The Series A - led by the GEC-KIP Technology and Innovation Fund with Korea Investment Partners, Golden Equator Ventures, SGInnovate and Asia Resource Corporation - was then the largest raised by a Singapore telemedicine company. The 2024 round, tied to the Good Doctor acquisition, brought Raffles Family Office, MDI Ventures and the SoftBank Vision Fund onto the register. Terms were not disclosed.
Southeast Asia's telehealth market is busy - Doctor Anywhere, Speedoc and MyDoc in Singapore; Halodoc and Alodokter in Indonesia; and insurer-backed offerings across the region. WhiteCoat's differentiation is less about a single feature and more about posture: video-first care, a compliance-led relationship with regulators, deep insurer and employer distribution, and a willingness to grow by acquisition.
The 2024 purchase of Good Doctor - described as the biggest merger of two dominant telehealth companies in Southeast Asia to date - folded Indonesia's large digital-health market into WhiteCoat's insurer network. The combined group, working with 130+ insurers and 7,500 corporate partners across four markets, is pitched as the region's largest and most comprehensive digital healthcare group, with GenAI slated to enter the care workflow next.
Founder Bryan Koh falls ill before a flight and is helped remotely by his doctor sister - the seed of the idea.
The app goes live in Singapore with video consultations and medication delivery, and enters the MOH telemedicine sandbox as its first startup.
Becomes AIA Singapore's exclusive telehealth provider, unlocking access to about two million users.
Reports 8x revenue growth and 7x more consultations as demand for remote care spikes.
Raises S$10.8M - then Singapore's largest telemedicine round - to fund regional expansion.
Surpasses 1.5 million consultations and medication fulfillments across its markets.
Acquires Indonesia's Good Doctor with backing from RFO, MDI Ventures and SoftBank Vision Fund, forming one of SEA's largest digital health groups.
The company's origin traces to a 2016 health scare hours before a flight to South Africa.
Founder Bryan Koh was a corporate lawyer before starting a healthcare company.
WhiteCoat targeted roughly 90-minute medication delivery by partnering with Grab.
It chose live video over text chat so doctors can see whether a patient needs in-person care.
The combined group operates in four markets and plans to enter at least two more.
It was the very first startup admitted to Singapore's MOH telemedicine sandbox.
WhiteCoat is a digital healthcare provider offering on-demand video consultations with licensed doctors, plus prescriptions, medication delivery, referrals and corporate health services across Southeast Asia.
It launched in 2018, founded by Bryan Koh, a former corporate lawyer, with his sister Natalie Koh as medical advisor. The concept dates to a 2016 personal health experience.
Headquartered in Singapore, it operates across Singapore, Indonesia, Malaysia and Vietnam, with plans to enter additional Asian markets.
Through consultation, prescription and delivery fees from consumers, and through contracts with insurers and corporate employers who embed WhiteCoat as their telehealth provider.
In 2024 WhiteCoat acquired Indonesia's Good Doctor in what was described as Southeast Asia's largest telehealth merger, creating a group serving over 6.8 million clients with 130+ insurers and 7,500 corporate partners.
WATCH & READ · Explore product demos and news coverage: